FDA Clearance Tracker · K241843
TD-7301 Spirometer (TD-7301)
Last checked: Nov 20, 2026Latest source record: Nov 20, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Nov 20, 2024
Substantially Equivalent
Time to decision
147 days
Received Jun 26, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K241843
- Device name
- TD-7301 Spirometer (TD-7301)
- Applicant
- Gostar Co., Ltd.
- Applicant location
- New Taipei City, TW
- Received
- Jun 26, 2024
- Decided
- Nov 20, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Spirometer, Diagnostic (BZG)
- Device class
- Class II
- Regulation
- 21 CFR 868.1840
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code BZG. The earliest in FDA's data is K770927, decided May 26, 1977.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K241843
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Gostar Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- TD-7301 Peak Flow meter510(k)
K222810 · Decided Dec 19, 2023 · 459 days after receipt
Device type: Meter, Peak Flow, Spirometry (BZH) · Anesthesiology & Respiratory
K221419 · Decided Jan 20, 2023 · 249 days after receipt
Device type: Multiple Use Blood Lancet For Single Patient Use Only (QRL) · General & Plastic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.